Man Group’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-135,624
| Closed | -$4.05M | – | 2457 |
|
|
2025
Q3 | $4.05M | Buy |
+135,624
| New | +$4.53M | 0.01% | 1152 |
|
|
2024
Q2 | – | Sell |
-9,389
| Closed | -$275K | – | 2257 |
|
|
2024
Q1 | $275K | Buy |
+9,389
| New | +$299K | ﹤0.01% | 1944 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1696 |
|
|
2021
Q1 | – | Sell |
-16,531
| Closed | -$720K | – | 1990 |
|
|
2020
Q4 | $720K | Sell |
16,531
-533
| -3% | -$21K | ﹤0.01% | 1475 |
|
|
2020
Q3 | $664K | Buy |
+17,064
| New | +$750K | ﹤0.01% | 1479 |
|
|
2019
Q2 | – | Sell |
-36,225
| Closed | -$1.57M | – | 1995 |
|
|
2019
Q1 | $1.57M | Sell |
36,225
-1,877
| -5% | -$95.6K | 0.01% | 1430 |
|
|
2018
Q4 | $1.8M | Sell |
38,102
-19,699
| -34% | -$1.18M | 0.01% | 1259 |
|
|
2018
Q3 | $4.32M | Buy |
57,801
+9,078
| +19% | +$625K | 0.02% | 1077 |
|
|
2018
Q2 | $2.69M | Buy |
48,723
+6,734
| +16% | +$311K | 0.01% | 1245 |
|
|
2018
Q1 | $1.6M | Buy |
+41,989
| New | +$1.3M | 0.01% | 1363 |
|
Other funds holding SRDX
Man Group's SRDX Position: Q4 2025 in Review
Man Group sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 135,624 shares — an estimated $4.05M sold.
Man Group first reported a position in SRDX in Q1 2018 and held it in 9 quarters. The position peaked at $4.32M in Q3 2018. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Man Group reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Man Group sold 135,624 Surmodics shares in Q4 2025, an estimated $4.05M.
- Man Group first reported a position in Surmodics in Q1 2018 and held it in 9 quarters.
- Man Group's Surmodics position peaked at $4.32M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Man Group's 13F filing for Q4 2025, filed 17 Feb 2026.